Cellectis Bioresearch SAS, a prominent player in the biotechnology sector, is headquartered in France and operates extensively across Europe and North America. Founded in 1999, the company has established itself as a leader in gene editing and cell engineering, focusing on innovative solutions for research and therapeutic applications. Cellectis is renowned for its proprietary technologies, including TALEN® gene editing tools, which offer precision and versatility in genetic modifications. This unique approach positions Cellectis at the forefront of the bioresearch industry, catering to a diverse clientele ranging from academic institutions to pharmaceutical companies. With a commitment to advancing genetic research, Cellectis has achieved significant milestones, including collaborations with major industry partners and contributions to groundbreaking studies. Its reputation for excellence and innovation solidifies its market position as a trusted provider of cutting-edge biotechnological solutions.
We don't have data for Cellectis Bioresearch SAS, but we can show you information about their parent organization instead.
View parent company